Clinical Trials

MilliporeSigma launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains…
Read More...

Compugen Ltd. disclosed that its LINKS computational platform, initially designed for the characterization and differentiation of existing novel drug target candidates, has been…
Read More...

Veeva Systems announced that Daiichi Sankyo Company, Limited (hereinafter, Daiichi Sankyo) based in Japan, selected Veeva Vault eTMF, Veeva Vault QualityDocs, and Veeva Vault…
Read More...

Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced the effectiveness of the exclusive licensing…
Read More...

Genmab has entered an agreement to grant Gilead Sciences an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop…
Read More...

Lantern Pharma has entered into an exclusive agreement to evaluate BioNumerik Pharmaceuticals' Tavocept for human therapeutic indications using Lantern’s 5-M theranostic platform.…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced the award of a $2 million research grant from the FDA’s Office of Orphan…
Read More...

Medidata announced that its cloud technology platform has been adopted by Pluristem Therapeutics. The Israeli biotech will deploy Medidata Rave to capture, manage and maximize the value…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced that the European Medicines Agency (EMA) has granted PRIority MEdicines…
Read More...

Synaffix has completed a new set of preclinical studies that further supports the potential for its technology to enable safer and more effective targeted cancer therapeutics. The…
Read More...

DNAtrix, a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer, announced the successful intratumoral administration of DNX-2401 with the Alcyone…
Read More...

PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS)…
Read More...

Medidata announced that it has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers. A Medidata customer since 2013, the …
Read More...

Oracle announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and…
Read More...

An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June. The…
Read More...

Delivra has entered into a technology licensing agreement with Kalytera Therapeutics. Based in California, Kalytera is a pharmaceutical company developing a portfolio of…
Read More...

PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to…
Read More...

Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer’s core strategic…
Read More...

As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as…
Read More...